Reply to: Assessing Clinical Utility of Datopotamab Deruxtecan Versus Chemotherapy for Breast Cancer

Aditya Bardia, Barbara Pistilli, Hope Rugo

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

langue originale	Anglais
Pages (de - à)	2137-2138
Nombre de pages	2
journal	Journal of Clinical Oncology
Volume	43
Numéro de publication	18
Les DOIs	https://doi.org/10.1200/JCO-24-02833
état	Publié - 20 juin 2025

Accès au document

@article{39a3cd35f6f24595a4761c86ac168ef7,

title = "Reply to: Assessing Clinical Utility of Datopotamab Deruxtecan Versus Chemotherapy for Breast Cancer",

author = "Aditya Bardia and Barbara Pistilli and Hope Rugo",

year = "2025",

month = jun,

day = "20",

doi = "10.1200/JCO-24-02833",

language = "English",

volume = "43",

pages = "2137--2138",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

number = "18",

}

TY - JOUR

T1 - Reply to

T2 - Assessing Clinical Utility of Datopotamab Deruxtecan Versus Chemotherapy for Breast Cancer

AU - Bardia, Aditya

AU - Pistilli, Barbara

AU - Rugo, Hope

PY - 2025/6/20

Y1 - 2025/6/20

UR - http://www.scopus.com/inward/record.url?scp=105008697061&partnerID=8YFLogxK

U2 - 10.1200/JCO-24-02833

DO - 10.1200/JCO-24-02833

M3 - Letter

C2 - 40153734

AN - SCOPUS:105008697061

SN - 0732-183X

VL - 43

SP - 2137

EP - 2138

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 18

ER -